Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
API-first, DPI-driven DDRS platform aims to modernize drug and medical device regulation in India
AI challenge offers Rs 10 lakh top prize and potential ?50 lakh deployment contract; applications open till April 17
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
